Evidence map›Paper›PMID 39447166›Full record

ArticleJMIR public health and surveillance2024

Infodemics and Vaccine Confidence: Protocol for Social Listening and Insight Generation to Inform Action.

Jessica Kolis, Kathryn Brookmeyer, Yulia Chuvileva, Christopher Voegeli, Sarina Juma, Atsuyoshi Ishizumi, Katy Renfro, Elisabeth Wilhelm, Hannah Tice, Hannah Fogarty and 3 more

Abstract read
In one paragraph

Article in JMIR public health and surveillance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jessica KolisGlobal Immunization Division, Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0001-6946-8849
Kathryn BrookmeyerOffice of the Director, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0003-3149-3509
Yulia ChuvilevaDivision of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0001-7335-6110
Christopher VoegeliOffice of the Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0002-1217-402X
Sarina JumaDivision of Workforce Development, National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0001-6335-5229
Atsuyoshi IshizumiGlobal Immunization Division, Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0001-9678-5372
Katy RenfroDivision of STD Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0003-4929-2545
Elisabeth WilhelmGlobal Immunization Division, Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0002-4641-516X
Hannah TiceDivision of State and Local Readiness, Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0003-3582-6470
Hannah FogartyDivision of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0001-5307-4693
Irma KocerDivision of HIV Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0002-2396-4940
Jordan HelmsDivision of HIV Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0002-1668-6575
Anisha VermaTanaq Support Services, Atlanta, GA, United States.ORCID 0000-0003-4540-7675

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the fall of 2020, the COVID-19 infodemic began to affect public confidence in and demand for COVID-19 vaccines in the United States. While polls indicated what consumers felt regarding COVID-19 vaccines, they did not provide an understanding of why they felt that way or the social and informational influences that factored into vaccine confidence and uptake. It was essential for us to better understand how information ecosystems were affecting the confidence in and demand for COVID-19 vaccines in the United States.

objectiveThe US Centers for Disease Control and Prevention (CDC) established an Insights Unit within the COVID-19 Response's Vaccine Task Force in January 2021 to assist the agency in acting more swiftly to address the questions, concerns, perceptions, and misinformation that appeared to be affecting uptake of COVID-19 vaccines. We established a novel methodology to rapidly detect and report on trends in vaccine confidence and demand to guide communication efforts and improve programmatic quality in near real time.

methodsWe identified and assessed data sources for inclusion through an informal landscape analysis using a snowball method. Selected data sources provided an expansive look at the information ecosystem of the United States regarding COVID-19 vaccines. The CDC's Vaccinate with Confidence framework and the World Health Organization's behavioral and social drivers for vaccine decision-making framework were selected as guiding principles for interpreting generated insights and their impact. We used qualitative thematic analysis methods and a consensus-building approach to identify prevailing and emerging themes, assess their potential threat to vaccine confidence, and propose actions to increase confidence and demand.

resultsAs of August 2022, we have produced and distributed 34 reports to >950 recipients within the CDC and externally. State and local health departments, nonprofit organizations, professional associations, and congressional committees have referenced and used the reports for learning about COVID-19 vaccine confidence and demand, developing communication strategies, and demonstrating how the CDC monitored and responded to misinformation. A survey of the reports' end users found that nearly 75% (40/53) of respondents found them "very" or "extremely" relevant and 52% (32/61) used the reports to inform communication strategies. In addition, our methodology underwent continuous process improvement to increase the rigor of the research process, the validity of the findings, and the usability of the reports.

conclusionsThis methodology can serve as a diagnostic technique for rapidly identifying opportunities for public health interventions and prevention. As the methodology itself is adaptable, it could be leveraged and scaled for use in a variety of public health settings. Furthermore, it could be considered beyond acute public health crises to support adherence to guidance and recommendations and could be considered within routine monitoring and surveillance systems.

Indexed as

COVID-19COVID-19 VaccinesCenters for Disease Control and Prevention, U.S.CommunicationHumansUnited StatesVaccination HesitancyCOVID-19 VaccinesCOVID-19disinformationinfodemicinfodemic managementinfodemiologymisinformationmixed methodsthematic analysisvaccine confidencevaccine demand

Identifiers

PMID39447166
PMCPMC11544329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.